Unlock instant, AI-driven research and patent intelligence for your innovation.

Histone deacetylase inhibitor as well as preparation method and application thereof

A technology of compound and solvate, applied in the field of histone deacetylase inhibitor and its preparation

Active Publication Date: 2019-05-03
HITGEN INC
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The currently developed HDAC inhibitors also have certain problems in terms of anticancer activity, toxicity and side effects, and subtype selectivity.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Histone deacetylase inhibitor as well as preparation method and application thereof
  • Histone deacetylase inhibitor as well as preparation method and application thereof
  • Histone deacetylase inhibitor as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0074] Embodiment 1 synthetic target product 1~7

[0075] The route for synthesizing target products 1-7 is as follows:

[0076]

[0077] 1. Synthesis of Intermediate 1

[0078] (1) Synthesis of intermediate 1a:

[0079]

[0080] Dissolve chlorosulfonyl isocyanate (11.8g, 83.2mmol) in dry dichloromethane (220mL), cool to 0°C, add 2-chloroethanol (6.70g, 83.2mmol) dropwise in dichloromethane under the protection of argon (220 mL) solution. After stirring and reacting for 30 minutes, a solution of aniline (8.53g, 91.5mmol) and triethylamine (16.8g, 166mmol, 23.1mL) in dichloromethane (220mL) was slowly added, and the reaction was stirred for 1 hour after rising to room temperature. The reaction was quenched by adding 0.2N hydrochloric acid (10 mL), and the pH was adjusted to 2.0 with concentrated hydrochloric acid. The organic layer was separated, washed successively with 0.05mol / L hydrochloric acid and water, and dried by adding anhydrous sodium sulfate. The solvent ...

Embodiment 2

[0110] Embodiment 2 synthetic target compound 8 and 9

[0111] The synthetic routes of target products 8 and 9 are as follows:

[0112]

[0113] 1. Synthesis of Intermediate 5

[0114] Synthesis of intermediates 5a and 5b:

[0115] Using the raw materials in Table 4, other conditions are the same as the synthesis method of intermediate 1a, and the obtained intermediates 5a and 5b and their corresponding structures and yields are shown in Table 4. Among them, the molar amount of raw material 1 corresponds to the aniline used in the preparation of 1a, the raw material 2 corresponds to the chlorosulfonyl isocyanate used in the preparation of 1a, the raw material 3 corresponds to the 2-chloroethanol used in the preparation of 1a, and other unmentioned raw materials or solvents and their reaction conditions are related to the preparation Same as in 1a.

[0116] Table 4 The raw materials used for the synthesis of intermediates 5a and 5b and the final yield

[0117]

[0118...

Embodiment 3

[0127] Embodiment 3 synthetic target compound 10~15

[0128] The route of synthesizing target products 10-15 is as follows:

[0129]

[0130] 1. Synthesis of intermediate 7

[0131]

[0132] Dissolve 2,3-dihydro-1H-pyrrolo[2,3-b]pyridine (5.00g, 41.6mmol) in DMF (140mL), add N-bromosuccinimide (8.89g, 49.9mmol ), stirred at room temperature for 3 hours. Add saturated ice-cold sodium bicarbonate solution, extract with ethyl acetate, wash with saturated sodium chloride solution, and add anhydrous sodium sulfate to dry. The solvent was evaporated under reduced pressure, and intermediate 7 (3.60 g, 18.1 mmol, yield 43%) was obtained after purification by column chromatography (eluent: petroleum ether / ethyl acetate=10:1 to 1:1).

[0133] 2. Synthesis of Intermediate 8:

[0134]

[0135] Intermediate 7 (2.00g, 10.1mmol), zinc cyanide (1.77g, 15.1mmol) and tetrakis(triphenylphosphine)palladium (1.16g, 1.00mmol) were dissolved in DMSO (30.0mL) under nitrogen protection ,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses histone deacetylase inhibitor as well as a preparation method and application thereof, the invention discloses a compound shown in a formula i, or a crystal form thereof or a pharmaceutically acceptable salt thereof, or a solvate thereof, or a prodrug thereof, or a metabolite thereof. The novel compound shown in the formula i disclosed by the invention shows good deacetylase inhibition activity, and provides new medicinal possibility for clinically treating diseases related to abnormal histone deacetylase activity.

Description

technical field [0001] The invention relates to a histone deacetylase inhibitor and its preparation method and application. Background technique [0002] Inactivation of genes that control cell growth in the body is a hallmark of tumorigenesis. The epigenetic mechanisms that cause gene inactivation mainly include DNA methylation, histone acetylation, and modifications of other components in the higher-order structure of chromatin. These modifications change the chromatin configuration, resulting in changes in the regulation of gene transcription. Improper cell proliferation, leading to tumors. [0003] Histone acetylation plays a central role in the regulation of transcription in eukaryotic cells. Histone acetylation is regulated by a pair of functionally antagonistic proteases, histone acetyltransferases (HATs) and histone deacetylases (HDACs). In normal cells, this pair of enzymes is in a state of dynamic balance. In general, increased histone acetylation level is asso...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D209/08C07D471/04A61K31/405A61K31/454A61K31/496A61K31/4545A61K31/437A61K31/444A61K31/404A61P35/00A61P35/02A61P37/02A61P29/00A61P25/00A61P31/12
Inventor 李进吴波尚巳耘廖伟吕鹏农云宏陈伟
Owner HITGEN INC